Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progression, Clinical”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04892134
What this trial is testing

Evaluation of Clinical, Morphologic and Biochemical Markers in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Medical University of Graz 500
Not applicableStudy completedNCT00241787
What this trial is testing

Progression of Sub-Clinical Atherosclerosis

Who this might be right for
AtherosclerosisCardiovascular DiseasesHeart Diseases+1 more
Tufts Medical Center 2,900
Testing effectiveness (Phase 2)Active Not RecruitingNCT04758533
What this trial is testing

Clinical Trial to Assess the Safety and Efficacy of AloCELYVIR With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Combination With Radiotherapy or Medulloblastoma in Monotherapy

Who this might be right for
Diffuse Intrinsic Pontine GliomaMedulloblastoma, Childhood, Recurrent
Hospital Infantil Universitario Niño Jesús, Madrid, Spain 13
Testing effectiveness (Phase 2)Study completedNCT01299948
What this trial is testing

Progression of HIV-Disease Under Low Dose Corticosteroids

Who this might be right for
HIV Disease Progression
Medical Mission Institute, Germany 326
Testing effectiveness (Phase 2)Active Not RecruitingNCT04685590
What this trial is testing

Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) Study

Who this might be right for
Alzheimer Disease, Early OnsetMild Cognitive Impairment
Washington University School of Medicine 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06746961
What this trial is testing

Efficacy and Safety of QL1706 Plus Lenvatinib As 2nd Line Theapy in Patients with Metastatic Esophageal Carcinoma After Disease Progression on ICIs Therapy

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
The First Affiliated Hospital of Zhengzhou University 49
Testing effectiveness (Phase 2)Looking for participantsNCT07109323
What this trial is testing

Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM

Who this might be right for
Ultra High Risk mm (uhr-mm), 18-70 Years Old, Suitable for ASCT. And Meet Any of the Following uhr-mm DefinitionsCytogenetics Ultra High RiskPrimary Refractory+4 more
Institute of Hematology & Blood Diseases Hospital, China 50
Post-approval studies (Phase 4)Study completedNCT00777127
What this trial is testing

Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses

Who this might be right for
Actinic Keratosis
MEDA Pharma GmbH & Co. KG 258
Not applicableStudy completedNCT06083272
What this trial is testing

VitalThings Guardian Contactless Monitoring

Who this might be right for
Respiratory DepressionRespiratory FailureDeterioration, Clinical
VitalThings 41
Testing effectiveness (Phase 2)Looking for participantsNCT06532539
What this trial is testing

Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

Who this might be right for
Endometrial NeoplasmsNeoplasm Recurrence, LocalNeoplasm Metastasis
Shandong Cancer Hospital and Institute 30
Not applicableStudy completedNCT07552753
What this trial is testing

Semi-occlusive Dressing for Pediatric Fingertip Amputations

Who this might be right for
Fingertip AmputationFinger Injuries
Medical University of Graz 24
Not applicableStudy completedNCT05117541
What this trial is testing

Social-environmental, Psychosocial, Behavioral, Clinical and Biological Drivers of Disparities in Liver Disease Progression Among Korean American With Chronic Hepatitis B Infection

Who this might be right for
Chronic Viral HepatitisHepatitis B Infection
Thomas Jefferson University 365
Not applicableStudy completedNCT00649246
What this trial is testing

Prospective Assessment in Newborns for Diabetes Autoimmunity

Who this might be right for
Type 1 DiabetesAutoimmunity
Augusta University 25,055
Not applicableStudy completedNCT02529722
What this trial is testing

Biomarkers for the Progression of IgA Nephropathy

Who this might be right for
IgA NephropathyGlomerular Diseases
Istanbul University 120
Not applicableStudy completedNCT01160094
What this trial is testing

Role of Early Versus Late Switch to Lapatinib-Capecitabine (TYCO)

Who this might be right for
Cancer
Novartis 288
Not applicableStudy completedNCT01435954
What this trial is testing

Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy

Who this might be right for
Benign Prostatic Hyperplasia
GlaxoSmithKline 13,551
Not applicableStudy completedNCT02474329
What this trial is testing

Real-PD Trial: Development of Clinical Prognostic Models for Parkinson's Disease

Who this might be right for
Parkinson's Disease
Radboud University Medical Center 304
Not applicableStudy completedNCT00879801
What this trial is testing

Genetic Physiopathology and Evolution of Type 2 Diabetes

Who this might be right for
Pre-Diabetes
University of Pisa 1,017
Testing effectiveness (Phase 2)WithdrawnNCT00685633
What this trial is testing

Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00444535
What this trial is testing

Lapatinib and Bevacizumab for Metastatic Breast Cancer

Who this might be right for
Neoplasms, Breast
Novartis Pharmaceuticals 52
Next Page